Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
22
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Hunter Heidi | Director | 4 | $20.9K | $0 | 2025-06-05 |
| Elling Christian E | Director, 10% Owner | 6 | $0 | $0 | 2025-06-05 |
| Hirth Peter | Director | 5 | $0 | $0 | 2025-06-05 |
| Collins Helen Louise | Director | 3 | $0 | $0 | 2025-06-05 |
| Glaub Kathleen Sereda | Director | 5 | $0 | $0 | 2025-06-05 |
| Smith David V | Director | 5 | $0 | $0 | 2025-06-05 |
| Ahmad Qasim Iftikhar | Chief Medical Officer | 4 | $26.6K | $0 | 2025-04-02 |
| Zocca Mai-Britt | Chief Executive Officer | 9 | $10.1K | $0 | 2025-04-02 |
| Sullivan Amy | Chief Financial Officer | 8 | $66.5K | $0 | 2025-04-02 |
| Burkavage Brian | Chief Accounting Officer | 6 | $10.2K | $0 | 2025-04-02 |
| Smith Devin Whittemore | General Counsel | 6 | $9.7K | $0 | 2025-04-02 |
| Novo Holdings A/S | 10% Owner | 10 | $14.57M | $1.89M | 2024-07-26 |
| Vivo Capital IX, LLC | 10% Owner | 2 | $6.41M | $0 | 2023-08-09 |
| Lundbeckfond Invest A/S | Director, 10% Owner | 7 | $30.00M | $0 | 2023-08-09 |
| Nielsen Jack | Director | 5 | $9.10M | $0 | 2023-06-08 |
| Al-Hajj Muhammad | Chief Scientific Officer | 1 | $0 | $0 | 2023-03-20 |
| Ehrnrooth Eva | Chief Medical Officer | 1 | $0 | $0 | 2023-03-20 |
| Malier Vanessa | Director | 6 | $4.55M | $0 | 2021-11-09 |
| Andersson Claus A. | Director | 5 | $1.05M | $0 | 2021-11-09 |
| Vivo Capital Fund IX, L.P. | 10% Owner | 3 | $9.10M | $0 | 2021-11-09 |
| HBM Healthcare Investments (Cayman) Ltd. | 10% Owner | 3 | $4.55M | $0 | 2021-11-09 |
| Vendola Keith A. | Chief Financial Officer | 1 | $0 | $0 | 2021-11-04 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Collins Helen Louise | Director | A Award deriv | 2025-06-05 | 2025-06-06 | 35,144 | — | $0 | 35,144 | SEC↗ |
| Elling Christian E | Director | A Award deriv | 2025-06-05 | 2025-06-06 | 35,144 | — | $0 | 35,144 | SEC↗ |
| Glaub Kathleen Sereda | Director | A Award deriv | 2025-06-05 | 2025-06-06 | 35,144 | — | $0 | 35,144 | SEC↗ |
| Hirth Peter | Director | A Award deriv | 2025-06-05 | 2025-06-06 | 35,144 | — | $0 | 35,144 | SEC↗ |
| Hunter Heidi | Director | A Award deriv | 2025-06-05 | 2025-06-06 | 35,144 | — | $0 | 35,144 | SEC↗ |
| Smith David V | Director | A Award deriv | 2025-06-05 | 2025-06-06 | 35,144 | — | $0 | 35,144 | SEC↗ |
| Hunter Heidi | Director | P Buy | 2025-05-30 | 2025-06-02 | 15,000 | $1.39 | $20.9K | 15,000 | SEC↗ |
| Ahmad Qasim Iftikhar | Chief Medical Officer | A Award deriv | 2025-04-02 | 2025-04-04 | 215,000 | — | $0 | 215,000 | SEC↗ |
| Burkavage Brian | Chief Accounting Officer | A Award deriv | 2025-04-02 | 2025-04-04 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Smith Devin Whittemore | General Counsel | A Award deriv | 2025-04-02 | 2025-04-04 | 140,000 | — | $0 | 140,000 | SEC↗ |
| Sullivan Amy | Chief Financial Officer | A Award deriv | 2025-04-02 | 2025-04-04 | 215,000 | — | $0 | 215,000 | SEC↗ |
| Zocca Mai-Britt | Chief Executive Officer | A Award deriv | 2025-04-02 | 2025-04-04 | 580,000 | — | $0 | 580,000 | SEC↗ |
| Smith Devin Whittemore | General Counsel | P Buy | 2024-12-23 | 2024-12-23 | 12,000 | $0.81 | $9.7K | 16,938 | SEC↗ |
| Sullivan Amy | Chief Financial Officer | P Buy | 2024-12-23 | 2024-12-23 | 10,250 | $0.83 | $8.5K | 84,632 | SEC↗ |
| Zocca Mai-Britt | Chief Executive Officer | P Buy | 2024-12-23 | 2024-12-23 | 12,500 | $0.81 | $10.1K | 49,891 | SEC↗ |
| Ahmad Qasim Iftikhar | Chief Medical Officer | P Buy | 2024-12-23 | 2024-12-26 | 31,350 | $0.85 | $26.6K | 31,350 | SEC↗ |
| Novo Holdings A/S | 10% Owner | S Sale | 2024-07-26 | 2024-07-26 | 23,478 | $1.31 | $30.8K | 4,354,449 | SEC↗ |
| Novo Holdings A/S | 10% Owner | S Sale | 2024-07-25 | 2024-07-26 | 51,522 | $1.33 | $68.5K | 4,377,927 | SEC↗ |
| Collins Helen Louise | Director | A Award deriv | 2024-06-06 | 2024-06-07 | 45,642 | — | $0 | 45,642 | SEC↗ |
| Elling Christian E | Director | A Award deriv | 2024-06-06 | 2024-06-07 | 45,642 | — | $0 | 45,642 | SEC↗ |
| Glaub Kathleen Sereda | Director | A Award deriv | 2024-06-06 | 2024-06-07 | 45,642 | — | $0 | 45,642 | SEC↗ |
| Hirth Peter | Director | A Award deriv | 2024-06-06 | 2024-06-07 | 45,642 | — | $0 | 45,642 | SEC↗ |
| Hunter Heidi | Director | A Award deriv | 2024-06-06 | 2024-06-07 | 45,642 | — | $0 | 45,642 | SEC↗ |
| Smith David V | Director | A Award deriv | 2024-06-06 | 2024-06-07 | 45,642 | — | $0 | 45,642 | SEC↗ |
| Novo Holdings A/S | 10% Owner | S Sale | 2024-05-10 | 2024-05-14 | 658,809 | $1.22 | $803.7K | 4,429,449 | SEC↗ |
| Ahmad Qasim Iftikhar | Chief Medical Officer | A Award deriv | 2024-03-15 | 2024-03-18 | 280,000 | — | $0 | 280,000 | SEC↗ |
| Burkavage Brian | Chief Accounting Officer | A Award deriv | 2024-03-15 | 2024-03-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Smith Devin Whittemore | General Counsel | A Award deriv | 2024-03-15 | 2024-03-18 | 185,000 | — | $0 | 185,000 | SEC↗ |
| Sullivan Amy | Chief Financial Officer | A Award deriv | 2024-03-15 | 2024-03-18 | 280,000 | — | $0 | 280,000 | SEC↗ |
| Zocca Mai-Britt | Chief Executive Officer | A Award deriv | 2024-03-15 | 2024-03-18 | 750,000 | — | $0 | 750,000 | SEC↗ |
| Novo Holdings A/S | 10% Owner | S Sale | 2024-02-09 | 2024-02-13 | 658,809 | $1.50 | $988.2K | 5,088,258 | SEC↗ |
| Burkavage Brian | Chief Accounting Officer | P Buy | 2023-11-22 | 2023-11-24 | 5,000 | $1.04 | $5.2K | 11,500 | SEC↗ |
| Burkavage Brian | Chief Accounting Officer | P Buy | 2023-11-21 | 2023-11-24 | 5,000 | $0.99 | $5.0K | 6,500 | SEC↗ |
| Collins Helen Louise | Director | A Award deriv | 2023-11-15 | 2023-11-17 | 64,238 | — | $0 | 64,238 | SEC↗ |
| Hunter Heidi | Director | A Award deriv | 2023-08-11 | 2023-08-15 | 64,238 | — | $0 | 64,238 | SEC↗ |
| Smith Devin Whittemore | General Counsel | A Award deriv | 2023-08-09 | 2023-08-09 | 4,938 | $0.13 | $642 | 4,938 | SEC↗ |
| Sullivan Amy | Chief Financial Officer | A Award deriv | 2023-08-09 | 2023-08-09 | 49,382 | $0.13 | $6.4K | 49,382 | SEC↗ |
| Zocca Mai-Britt | Chief Executive Officer | A Award deriv | 2023-08-09 | 2023-08-09 | 37,037 | $0.13 | $4.8K | 37,037 | SEC↗ |
| Vivo Capital IX, LLC | 10% Owner | P Buy deriv | 2023-08-09 | 2023-08-10 | 3,157,894 | $0.13 | $410.5K | 3,157,894 | SEC↗ |
| Novo Holdings A/S | 10% Owner | P Buy deriv | 2023-08-09 | 2023-08-11 | 2,469,135 | $2.03 | $5.01M | 2,469,135 | SEC↗ |
| Lundbeckfond Invest A/S | Director, 10% Owner | A Award deriv | 2023-08-09 | 2023-08-11 | 7,901,234 | $0.13 | $1.03M | 7,901,234 | SEC↗ |
| Elling Christian E | Director, 10% Owner | A Award deriv | 2023-08-09 | 2023-08-11 | 7,901,234 | $0.13 | $1.03M | 7,901,234 | SEC↗ |
| Smith Devin Whittemore | General Counsel | A Award | 2023-08-09 | 2023-08-09 | 4,938 | $1.90 | $9.4K | 4,938 | SEC↗ |
| Sullivan Amy | Chief Financial Officer | A Award | 2023-08-09 | 2023-08-09 | 49,382 | $1.90 | $93.8K | 74,382 | SEC↗ |
| Zocca Mai-Britt | Chief Executive Officer | A Award | 2023-08-09 | 2023-08-09 | 37,037 | $1.90 | $70.4K | 37,391 | SEC↗ |
| Vivo Capital IX, LLC | 10% Owner | P Buy | 2023-08-09 | 2023-08-10 | 3,157,894 | $1.90 | $6.00M | 3,157,894 | SEC↗ |
| Novo Holdings A/S | 10% Owner | P Buy | 2023-08-09 | 2023-08-11 | 2,469,135 | $2.03 | $5.01M | 5,707,467 | SEC↗ |
| Lundbeckfond Invest A/S | Director, 10% Owner | A Award | 2023-08-09 | 2023-08-11 | 7,901,234 | $1.90 | $15.01M | 13,950,686 | SEC↗ |
| Elling Christian E | Director, 10% Owner | A Award | 2023-08-09 | 2023-08-11 | 7,901,234 | $1.90 | $15.01M | 13,950,686 | SEC↗ |
| Ahmad Qasim Iftikhar | Chief Medical Officer | A Award deriv | 2023-07-17 | 2023-07-19 | 288,153 | — | $0 | 288,153 | SEC↗ |
| Elling Christian E | Director | A Award deriv | 2023-06-08 | 2023-06-13 | 41,533 | — | $0 | 41,533 | SEC↗ |
| Glaub Kathleen Sereda | Director | A Award deriv | 2023-06-08 | 2023-06-13 | 41,533 | — | $0 | 41,533 | SEC↗ |
| Hirth Peter | Director | A Award deriv | 2023-06-08 | 2023-06-13 | 41,533 | — | $0 | 41,533 | SEC↗ |
| Nielsen Jack | Director | A Award deriv | 2023-06-08 | 2023-06-13 | 41,533 | — | $0 | 41,533 | SEC↗ |
| Smith David V | Director | A Award deriv | 2023-06-08 | 2023-06-13 | 41,533 | — | $0 | 41,533 | SEC↗ |
| Ehrnrooth Eva | Chief Medical Officer | A Award deriv | 2023-03-20 | 2023-03-22 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Burkavage Brian | Chief Accounting Officer | A Award deriv | 2023-03-20 | 2023-03-22 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Sullivan Amy | Chief Financial Officer | A Award deriv | 2023-03-20 | 2023-03-22 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Zocca Mai-Britt | Chief Executive Officer | A Award deriv | 2023-03-20 | 2023-03-22 | 500,000 | — | $0 | 500,000 | SEC↗ |
| Al-Hajj Muhammad | Chief Scientific Officer | A Award deriv | 2023-03-20 | 2023-03-22 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Sullivan Amy | Chief Financial Officer | P Buy | 2023-03-17 | 2023-03-20 | 25,000 | $2.32 | $58.0K | 25,000 | SEC↗ |
| Smith Devin Whittemore | General Counsel | A Award deriv | 2023-01-12 | 2023-01-13 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Sullivan Amy | Chief Financial Officer | A Award deriv | 2022-10-17 | 2022-10-19 | 288,152 | — | $0 | 288,152 | SEC↗ |
| Burkavage Brian | Chief Accounting Officer | A Award deriv | 2022-05-31 | 2022-06-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Nielsen Jack | Director | A Award deriv | 2022-05-26 | 2022-05-31 | 23,885 | — | $0 | 23,885 | SEC↗ |
| Elling Christian E | Director | A Award deriv | 2022-05-26 | 2022-05-31 | 23,885 | — | $0 | 23,885 | SEC↗ |
| Glaub Kathleen Sereda | Director | A Award deriv | 2022-05-26 | 2022-05-31 | 23,885 | — | $0 | 23,885 | SEC↗ |
| Smith David V | Director | A Award deriv | 2022-05-26 | 2022-05-31 | 23,885 | — | $0 | 23,885 | SEC↗ |
| Hirth Peter | Director | A Award deriv | 2022-05-26 | 2022-05-31 | 23,885 | — | $0 | 23,885 | SEC↗ |
| Smith David V | Director | A Award deriv | 2022-03-01 | 2022-03-03 | 28,019 | — | $0 | 28,019 | SEC↗ |
| Novo Holdings A/S | 10% Owner | C Conversion deriv | 2021-11-09 | 2021-11-10 | 75,267 | — | $0 | 0 | SEC↗ |
| Novo Holdings A/S | 10% Owner | C Conversion deriv | 2021-11-09 | 2021-11-10 | 217,107 | — | $0 | 0 | SEC↗ |
| Nielsen Jack | Director | C Conversion deriv | 2021-11-09 | 2021-11-12 | 188,168 | — | $0 | 0 | SEC↗ |
| Lundbeckfond Invest A/S | 10% Owner | C Conversion deriv | 2021-11-09 | 2021-11-12 | 150,534 | — | $0 | 0 | SEC↗ |
| Lundbeckfond Invest A/S | 10% Owner | C Conversion deriv | 2021-11-09 | 2021-11-12 | 219,595 | — | $0 | 0 | SEC↗ |
| Zocca Mai-Britt | Chief Executive Officer | C Conversion deriv | 2021-11-09 | 2021-11-12 | 26,580 | — | $0 | 0 | SEC↗ |
| Malier Vanessa | Director | C Conversion deriv | 2021-11-09 | 2021-11-12 | 21,325 | — | $0 | 0 | SEC↗ |
| Malier Vanessa | Director | C Conversion deriv | 2021-11-09 | 2021-11-12 | 63,350 | — | $0 | 0 | SEC↗ |
| Andersson Claus A. | Director | C Conversion deriv | 2021-11-09 | 2021-11-12 | 147,881 | — | $0 | 0 | SEC↗ |
| Andersson Claus A. | Director | C Conversion deriv | 2021-11-09 | 2021-11-12 | 28,225 | — | $0 | 0 | SEC↗ |
| Vivo Capital Fund IX, L.P. | 10% Owner | C Conversion deriv | 2021-11-09 | 2021-11-12 | 188,168 | — | $0 | 0 | SEC↗ |
| HBM Healthcare Investments (Ca | 10% Owner | C Conversion deriv | 2021-11-09 | 2021-11-12 | 188,168 | — | $0 | 0 | SEC↗ |
| Novo Holdings A/S | 10% Owner | C Conversion | 2021-11-09 | 2021-11-10 | 2,952,932 | — | $0 | 2,952,932 | SEC↗ |
| Novo Holdings A/S | 10% Owner | P Buy | 2021-11-09 | 2021-11-10 | 325,000 | $14.00 | $4.55M | 3,277,932 | SEC↗ |
| Nielsen Jack | Director | C Conversion | 2021-11-09 | 2021-11-12 | 2,365,545 | — | $0 | 2,365,545 | SEC↗ |
| Nielsen Jack | Director | P Buy | 2021-11-09 | 2021-11-12 | 650,000 | $14.00 | $9.10M | 3,015,545 | SEC↗ |
| Lundbeckfond Invest A/S | 10% Owner | P Buy | 2021-11-09 | 2021-11-12 | 2,142,857 | $14.00 | $30.00M | 6,049,452 | SEC↗ |
| Lundbeckfond Invest A/S | 10% Owner | C Conversion | 2021-11-09 | 2021-11-12 | 1,892,434 | — | $0 | 3,906,595 | SEC↗ |
| Lundbeckfond Invest A/S | 10% Owner | C Conversion | 2021-11-09 | 2021-11-12 | 2,014,161 | — | $0 | 2,014,161 | SEC↗ |
| Zocca Mai-Britt | Chief Executive Officer | C Conversion | 2021-11-09 | 2021-11-12 | 26,580 | — | $0 | 26,580 | SEC↗ |
| Malier Vanessa | Director | P Buy | 2021-11-09 | 2021-11-12 | 162,500 | $14.00 | $2.27M | 430,477 | SEC↗ |
| Malier Vanessa | Director | C Conversion | 2021-11-09 | 2021-11-12 | 267,977 | — | $0 | 267,977 | SEC↗ |
| Malier Vanessa | Director | C Conversion | 2021-11-09 | 2021-11-12 | 796,059 | — | $0 | 796,059 | SEC↗ |
| Malier Vanessa | Director | P Buy | 2021-11-09 | 2021-11-12 | 162,500 | $14.00 | $2.27M | 958,559 | SEC↗ |
| Andersson Claus A. | Director | P Buy | 2021-11-09 | 2021-11-12 | 75,000 | $14.00 | $1.05M | 1,791,490 | SEC↗ |
| Andersson Claus A. | Director | C Conversion | 2021-11-09 | 2021-11-12 | 1,361,660 | — | $0 | 1,361,660 | SEC↗ |
| Andersson Claus A. | Director | C Conversion | 2021-11-09 | 2021-11-12 | 354,830 | — | $0 | 1,716,490 | SEC↗ |
| Vivo Capital Fund IX, L.P. | 10% Owner | P Buy | 2021-11-09 | 2021-11-12 | 650,000 | $14.00 | $9.10M | 3,015,545 | SEC↗ |
| Vivo Capital Fund IX, L.P. | 10% Owner | C Conversion | 2021-11-09 | 2021-11-12 | 2,365,545 | — | $0 | 2,365,545 | SEC↗ |
| HBM Healthcare Investments (Ca | 10% Owner | P Buy | 2021-11-09 | 2021-11-12 | 325,000 | $14.00 | $4.55M | 2,690,545 | SEC↗ |
| HBM Healthcare Investments (Ca | 10% Owner | C Conversion | 2021-11-09 | 2021-11-12 | 2,365,545 | — | $0 | 2,365,545 | SEC↗ |
| Zocca Mai-Britt | Chief Executive Officer | A Award deriv | 2021-11-04 | 2021-11-08 | 414,212 | — | $0 | 414,212 | SEC↗ |
| Hirth Peter | Director | A Award deriv | 2021-11-04 | 2021-11-08 | 34,731 | — | $0 | 34,731 | SEC↗ |
| Vendola Keith A. | Chief Financial Officer | A Award deriv | 2021-11-04 | 2021-11-08 | 69,469 | — | $0 | 69,469 | SEC↗ |
| Glaub Kathleen Sereda | Director | A Award deriv | 2021-11-04 | 2021-11-08 | 21,295 | — | $0 | 21,295 | SEC↗ |